Renpeng Zhou

1.6k total citations
68 papers, 1.2k citations indexed

About

Renpeng Zhou is a scholar working on Molecular Biology, Immunology and Rheumatology. According to data from OpenAlex, Renpeng Zhou has authored 68 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 13 papers in Immunology and 12 papers in Rheumatology. Recurrent topics in Renpeng Zhou's work include Ion Transport and Channel Regulation (10 papers), Ion channel regulation and function (9 papers) and Osteoarthritis Treatment and Mechanisms (7 papers). Renpeng Zhou is often cited by papers focused on Ion Transport and Channel Regulation (10 papers), Ion channel regulation and function (9 papers) and Osteoarthritis Treatment and Mechanisms (7 papers). Renpeng Zhou collaborates with scholars based in China, United States and Saint Kitts and Nevis. Renpeng Zhou's co-authors include Feihu Chen, Wei Hu, Jin‐Fang Ge, Xiaoshan Wu, Yong Chen, Chao Lu, Dai B, Yingjie Zhao, Zhi‐Gang Xiong and Gui‐Ling Ren and has published in prestigious journals such as Stroke, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Renpeng Zhou

62 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renpeng Zhou China 19 679 246 230 174 159 68 1.2k
Hui Lin China 21 628 0.9× 170 0.7× 268 1.2× 124 0.7× 165 1.0× 51 1.2k
Michele Scuruchi Italy 21 435 0.6× 215 0.9× 176 0.8× 238 1.4× 64 0.4× 54 1.1k
Jun Chang China 21 550 0.8× 325 1.3× 318 1.4× 103 0.6× 93 0.6× 73 1.2k
Chih‐Yang Lin Taiwan 24 670 1.0× 304 1.2× 372 1.6× 197 1.1× 233 1.5× 58 1.4k
Yi‐Chin Fong Taiwan 22 546 0.8× 124 0.5× 251 1.1× 161 0.9× 109 0.7× 35 1.1k
Ömer Faruk Hatipoğlu Japan 18 312 0.5× 213 0.9× 181 0.8× 83 0.5× 76 0.5× 49 761
Raghunatha R. Yammani United States 21 633 0.9× 528 2.1× 177 0.8× 171 1.0× 79 0.5× 35 1.3k
Chen‐Ming Su Taiwan 25 726 1.1× 329 1.3× 313 1.4× 220 1.3× 112 0.7× 57 1.5k

Countries citing papers authored by Renpeng Zhou

Since Specialization
Citations

This map shows the geographic impact of Renpeng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renpeng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renpeng Zhou more than expected).

Fields of papers citing papers by Renpeng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renpeng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renpeng Zhou. The network helps show where Renpeng Zhou may publish in the future.

Co-authorship network of co-authors of Renpeng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Renpeng Zhou. A scholar is included among the top collaborators of Renpeng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renpeng Zhou. Renpeng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Qi, Yingjie Zhao, Qiuxia Yu, et al.. (2025). Effects of Histone Deacetylases (HDACs) in Programmed Cell Death: Execution Mechanism and Regulatory Pathways. Cell Biology International. 50(1). e70105–e70105.
2.
Wu, Qi, Yan Qin, Yanan Chen, et al.. (2025). G3BP2 facilitates abnormal activation of fibroblast-like synoviocytes through p53 signaling pathway in rheumatoid arthritis. International Immunopharmacology. 168(Pt 2). 115961–115961.
3.
Cheng, Yuanzhi, Fan Yang, Renpeng Zhou, et al.. (2025). A Phase I Study to Evaluate the Relative Bioavailability, Pharmacodynamics, and Safety of a Single Subcutaneous Injection of Recaticimab at Three Different Sites in Healthy Chinese Subjects. European Journal of Drug Metabolism and Pharmacokinetics. 50(3). 265–272.
4.
Wang, Hao, Yingjie Zhao, Fan Chen, et al.. (2025). Peroxiredoxin 6: A Regulatory Target in Cellular Senescence and Age-Related Diseases. Antioxidants and Redox Signaling. 43(7-9). 400–426. 1 indexed citations
5.
Dai, Min, Jie Ding, Weirong Hu, et al.. (2025). From pathogenesis to therapeutic targeting: new insight into TAM receptors in rheumatoid arthritis. Cell & Bioscience. 15(1). 157–157.
6.
Xing, Jing, Ke Wang, Qiuxia Yu, et al.. (2024). Efferocytosis: Unveiling its potential in autoimmune disease and treatment strategies. Autoimmunity Reviews. 23(6). 103578–103578. 14 indexed citations
7.
Zhao, Yingjie, Qiuxia Yu, Weirong Hu, et al.. (2024). Extracellular CIRP induces abnormal activation of fibroblast-like synoviocytes from patients with RA via the TLR4-mediated HDAC3 pathways. International Immunopharmacology. 128. 111525–111525. 7 indexed citations
8.
Zhou, Renpeng, Weirong Hu, X. Peter, & Liu C. (2024). Versatility of 14-3-3 proteins and their roles in bone and joint-related diseases. Bone Research. 12(1). 58–58. 5 indexed citations
9.
Wang, Yan, Ziwei Ouyang, Wen‐Juan Hao, et al.. (2023). Targeting regulated chondrocyte death in osteoarthritis therapy. Biochemical Pharmacology. 215. 115707–115707. 35 indexed citations
10.
Zhao, Yingjie, Cheng Sun, Fan Chen, et al.. (2023). ASIC1a-CMPK2-mediated M1 macrophage polarization exacerbates chondrocyte senescence in osteoarthritis through IL-18. International Immunopharmacology. 124(Pt A). 110878–110878. 16 indexed citations
11.
Ding, Jie, Yong Chen, Yingjie Zhao, et al.. (2022). Acid-sensitive ion channel 1a mediates osteoarthritis chondrocyte senescence by promoting Lamin B1 degradation. Biochemical Pharmacology. 202. 115107–115107. 12 indexed citations
12.
Zhou, Renpeng, Hongyu Liang, Weirong Hu, et al.. (2022). Modulators of ASIC1a and its potential as a therapeutic target for age-related diseases. Ageing Research Reviews. 83. 101785–101785. 10 indexed citations
13.
Lin, Yi, Yingjie Zhao, Hailin Zhang, et al.. (2022). Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis. Frontiers in Immunology. 13. 997621–997621. 16 indexed citations
15.
Zhou, Renpeng, Yong Chen, Yang� Yang, et al.. (2021). Systemic pharmacological verification of Baixianfeng decoction regulating TNF-PI3K-Akt-NF-κB pathway in treating rheumatoid arthritis. Bioorganic Chemistry. 119. 105519–105519. 18 indexed citations
16.
Zhou, Renpeng, Yong Chen, Xin Wei, et al.. (2020). Novel insights into ferroptosis: Implications for age-related diseases. Theranostics. 10(26). 11976–11997. 101 indexed citations
17.
Zhou, Renpeng, Dai B, Xiaoshan Wu, et al.. (2017). Interleukin-1β and tumor necrosis factor-α augment acidosis-induced rat articular chondrocyte apoptosis via nuclear factor-kappaB-dependent upregulation of ASIC1a channel. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(1). 162–177. 47 indexed citations
18.
Li, Yue, Renpeng Zhou, Dai B, et al.. (2017). Effects of autophagy on acid-sensing ion channel 1a-mediated apoptosis in rat articular chondrocytes. Molecular and Cellular Biochemistry. 443(1-2). 181–191. 11 indexed citations
19.
Zhou, Renpeng, et al.. (2016). Novel Insights into Acid-Sensing Ion Channels: Implications for Degenerative Diseases. Aging and Disease. 7(4). 491–491. 45 indexed citations
20.
Zhou, Renpeng, Xiaoshan Wu, Zhisen Wang, Jin‐Fang Ge, & Feihu Chen. (2015). Interleukin-6 enhances acid-induced apoptosis via upregulating acid-sensing ion channel 1a expression and function in rat articular chondrocytes. International Immunopharmacology. 29(2). 748–760. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026